Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Benjamin Rhodes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
The complement receptor 3 (CD11b/CD18) agonist Leukadherin-1 suppresses human innate inflammatory signalling
Roberts, A. L., Fürnrohr, B. G., Vyse, T. J. & Rhodes, B., 1 Sept 2016, In: Clinical and Experimental Immunology. 185, 3, p. 361-371 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile16 Citations (Scopus)196 Downloads (Pure) -
Reduced fluorescence versus forward scatter time-of-flight and increased peak versus integral fluorescence ratios indicate receptor clustering in flow cytometry
Fürnrohr, B. G., Stein, M., Rhodes, B., Chana, P. S., Schett, G., Vyse, T. J., Herrmann, M. & Mielenz, D., 1 Jul 2015, In: Journal of Immunology. 195, 1, p. 377-385 9 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Resequencing the susceptibility gene, ITGAM, identifies two functionally deleterious rare variants in systemic lupus erythematosus cases
Roberts, A. L., Thomas, E., Bhosle, S., Game, L., Obraztsova, O., Aitman, T. J., Vyse, T. J. & Rhodes, B., 21 May 2014, In: Arthritis Research and Therapy. 16, 3, 11 p., R114.Research output: Contribution to journal › Article › peer-review
Open Access20 Citations (Scopus) -
Systemic Lupus Erythematosus
Rhodes, B. & Vyse, T. J., 29 Aug 2013, Genomic and Personalized Medicine. Ginsburg, G. S. & Willard, H. F. (eds.). 2 ed. Amsterdam: ELSEVIER ACADEMIC PRESS INC, Vol. 1-2. p. 970-982 13 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes
Rhodes, B., Fürnrohr, B. G., Roberts, A. L., Tzircotis, G., Schett, G., Spector, T. D. & Vyse, T. J., Dec 2012, In: Annals of the Rheumatic Diseases. 71, 12, p. 2028-2034 7 p.Research output: Contribution to journal › Article › peer-review
Open Access71 Citations (Scopus)
Projects
- 5 Finished
-
Targeting complement receptor 3 - a novel therapeutic approach in systemic lupus erythematosus
Rhodes, B. (Primary Investigator)
1/09/2013 → 31/08/2016
Project: Research
-
Genetic variation at ITGAM and the mechanism by which it predisposes to SLE
Rhodes, B. (Primary Investigator)
28/08/2013 → 27/10/2013
Project: Research
-
Complement receptor 3 variation and the immunogenetics of the human cellular innate immune system in systemic lupus erythematosus
Rhodes, B. (Primary Investigator) & Vyse, T. (Co-Investigator)
1/04/2013 → 31/03/2017
Project: Research
-
In vitro analysis of phagocyte receptors in SLE pathogenesis
Rhodes, B. (Primary Investigator) & Vyse, T. (Primary Investigator)
1/01/2011 → 31/12/2013
Project: Research
-
Genetic variation at ITGAM and the mechanism by which it predisposes to SLE
Rhodes, B. (Primary Investigator) & Vyse, T. (Primary Investigator)
1/11/2010 → 31/07/2013
Project: Research